Funder
National Institute of Nursing Research
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Reference46 articles.
1. Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91(2):74–81. https://doi.org/10.1212/WNL.0000000000005755.
2. Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91(2):82–90. https://doi.org/10.1212/WNL.0000000000005756.
3. Patel H, Toe DC, Burke S, Rasu RS. Anticonvulsant use after formulary status change for brand-name second-generation anticonvulsants. Am J Manag Care. 2010;16(8):e197–204.
4. Drug Label: Pregabalin. US Food and Drug Administration; 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021446s035,022488s013lbl.pdf. Accessed 17 Nov 2019.
5. Garrard J, Harms S, Hardie N, et al. Antiepileptic drug use in nursing home admissions. Ann Neurol. 2003;54(1):75–85. https://doi.org/10.1002/ana.10593.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献